translating cancer research targeted therapeutics 
emphasis cancer drug development shifted cytotoxic non-specific chemotherapies molecularly targeted rationally designed drugs promising greater efficacy less side effects nevertheless despite successes drug development remains painfully slow highlight issues involved suggest ways process can improved expedited envision increasing shift integrated cancer research biomarker-driven adaptive hypothesis testing clinical trials goal development specific cancer medicines treat individual patient treatment selection driven detailed understanding genetics biology patient cancer 
